XIAOMI-W
01810
BABA-W
09988
ALI HEALTH
00241
KUAISHOU-W
01024
BIDU-SW
09888
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q3)Mar 31, 2021 | (FY)Dec 31, 2020 | (Q3)Mar 31, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -50.81%308.55M | -1.07%621.02M | 93.38%627.26M | 7.71%627.73M | --324.36M | 44.67%582.8M | 45.02%104.18M | 25.44%402.84M | --71.84M | 13.87%321.15M |
Operating income | -50.81%308.55M | -1.07%621.02M | 93.38%627.26M | 7.71%627.73M | 324.36M | 44.67%582.8M | 45.02%104.18M | 25.44%402.84M | 71.84M | 13.87%321.15M |
Cost of sales | ---- | ---- | ---- | ---- | ---- | -34.57%-434.95M | -47.16%-80.67M | -21.91%-323.22M | ---54.82M | -12.46%-265.12M |
Operating expenses | 54.85%-248.09M | -5.36%-503.96M | -122.47%-549.44M | -9.97%-478.32M | -246.98M | -34.57%-434.95M | -47.16%-80.67M | -21.91%-323.22M | -54.82M | -12.46%-265.12M |
Gross profit | -22.32%60.46M | -21.65%117.07M | 0.56%77.82M | 1.06%149.41M | 77.39M | 85.69%147.85M | 38.13%23.52M | 42.12%79.62M | 17.02M | 21.06%56.02M |
Selling expenses | ---- | ---- | ---9.9M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Administrative expenses | -17.15%-23.57M | -10.16%-55.3M | -4.75%-20.12M | 4.79%-50.2M | ---19.21M | -93.43%-52.72M | -114.59%-7.35M | -23.93%-27.26M | ---3.43M | -38.40%-21.99M |
Research and development expenses | -11.65%-2.46M | 17.52%-4.23M | 6.68%-2.21M | ---5.12M | ---2.36M | ---- | ---- | ---- | ---- | ---- |
Impairment and provision | -15.32%-7.36M | -61.72%-8.54M | -43.57%-6.38M | -40.62%-5.28M | ---4.45M | -1,732.68%-3.76M | -9.54%-1.05M | 6.82%-205K | ---954K | 68.57%-220K |
-Other impairment is provision | -15.32%-7.36M | -61.72%-8.54M | -43.57%-6.38M | -40.62%-5.28M | ---4.45M | -1,732.68%-3.76M | -9.54%-1.05M | 6.82%-205K | ---954K | 68.57%-220K |
Special items of operating profit | -94.39%51.93K | -25.51%2.81M | -31.36%925.81K | 14.31%3.77M | --1.35M | 79.52%3.3M | 234.68%415K | 83.97%1.84M | --124K | 390.96%998K |
Operating profit | -10.82%25.2M | -46.77%46.77M | -44.44%28.25M | -7.19%87.86M | 50.85M | 75.32%94.66M | 21.66%15.53M | 55.12%53.99M | 12.77M | 18.63%34.81M |
Financing income | ---- | ---- | ---- | ---- | ---- | 1.25%5.85M | 124.84%3.58M | 14.98%5.77M | --1.59M | 13.29%5.02M |
Financing cost | -0.43%2.29M | -65.20%4.58M | 80.18%2.3M | 587.14%13.15M | --1.28M | -207.52%-2.7M | ---2.54M | ---878K | ---- | ---- |
Special items of earning before tax | 1,246.20%1.41M | -284.82%-284.01K | -231.50%-123.02K | --153.67K | --93.55K | ---- | ---- | ---- | ---- | ---- |
Earning before tax | -5.04%28.9M | -49.53%51.06M | -41.73%30.43M | 3.44%101.17M | 52.22M | 66.09%97.81M | 15.42%16.58M | 47.86%58.89M | 14.36M | 17.93%39.83M |
Tax | 17.34%-6.97M | 52.51%-10.8M | 26.12%-8.43M | -9.35%-22.74M | ---11.41M | -53.71%-20.79M | -20.21%-4.04M | -24.17%-13.53M | ---3.36M | -17.05%-10.89M |
After-tax profit from continuing operations | -0.33%21.93M | -48.67%40.26M | -46.09%22M | 1.84%78.43M | 40.81M | 69.78%77.02M | 13.96%12.54M | 56.78%45.36M | 11M | 18.26%28.93M |
Earning after tax | -0.33%21.93M | -48.67%40.26M | -46.09%22M | 1.84%78.43M | 40.81M | 69.78%77.02M | 13.96%12.54M | 56.78%45.36M | 11M | 18.26%28.93M |
Minority profit | -66.52%261.55K | -46.68%828.74K | 14.82%781.19K | 28.78%1.55M | --680.39K | 1,911.67%1.21M | ---226K | --60K | ---- | ---- |
Profit attributable to shareholders | 2.11%21.67M | -48.71%39.43M | -47.13%21.22M | 1.41%76.88M | 40.13M | 67.34%75.81M | 16.02%12.76M | 56.57%45.3M | 11M | 18.26%28.93M |
Basic earnings per share | 0.00%0.16 | -54.55%0.3 | -60.00%0.16 | -13.16%0.66 | 0.4 | 0.76 | ||||
Diluted earnings per share | 0.00%0.16 | -54.55%0.3 | -60.00%0.16 | -13.16%0.66 | 0.4 | 0.76 | ||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Dahua Certified Public Accountants (Special General Partnership) | -- | KPMG | -- | KPMG | -- | KPMG | -- | KPMG |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.